As of 2025-08-23, the Fair Value of Orphazyme A/S (ORPHA.CO) is -1,427.00 DKK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 915.00 DKK, the upside of Orphazyme A/S is -255.96%.
With the market price of 915.00 DKK and our fair value calculation, Orphazyme A/S (ORPHA.CO) is not a good investment. Investing in ORPHA.CO stocks now will result in a potential loss of 255.96%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
Historical Earnings | ||||||
2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
Net income | -337.50 | -633.25 | -626.54 | 35.07 | -26.05 | -317.65 |
YoY growth | -46.99% | -87.63% | 1.06% | 105.60% | -174.27% | -40.45% |
Market Cap (mil) | 36.60 |
P/E | |
Forward P/E |
EPS | -285.40 |
Avg earnings growth rate | -40.45% |
TTM earnings | -11.42 |